share_log

Shuttle Pharmaceuticals | 8-K: Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharmaceuticals | 8-K: Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharmaceuticals | 8-K:Shuttle Pharma收到纳斯达克不遵守上市规则5250 (c) (1)通知
美股SEC公告 ·  08/26 16:12
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息